Comparison of long-term efficacy and safety between cilostazol and clopidogrel in chronic ischemic stroke: a nationwide cohort study
Background: Previous clinical trials showed a significant difference in efficacy and safety among antiplatelets in acute ischemic stroke (IS). The present study wished to compare the efficacy and safety head-to-head between cilostazol and clopidogrel in chronic IS. Methods: This open prospective coh...
Saved in:
Main Authors: | Tsong-Hai Lee (Author), Yu-Sheng Lin (Author), Chia-Wei Liou (Author), Jiann-Der Lee (Author), Tsung-I Peng (Author), Chi-Hung Liu (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2020-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk of Heart Failure Hospitalization Associated With Cilostazol in Diabetes: A Nationwide Case-Crossover Study
by: Cho-Kai Wu, et al.
Published: (2019) -
Benefits and Risks of Clopidogrel vs. Aspirin Monotherapy after Recent Ischemic Stroke: A Systematic Review and Meta-Analysis
by: Maurizio Paciaroni, et al.
Published: (2019) -
Protective effects of cilostazol against hemorrhagic stroke: Current and future perspectives
by: Toshinori Takagi, et al.
Published: (2016) -
Early Blood Glucose Level Post-Admission Correlates with the Outcomes and Oxidative Stress in Neonatal Hypoxic-Ischemic Encephalopathy
by: Inn-Chi Lee, et al.
Published: (2021) -
Personalized antiplatelet therapy guided by clopidogrel pharmacogenomics in acute ischemic stroke and transient ischemic attack: A prospective, randomized controlled trial
by: Xiaoguang Zhang, et al.
Published: (2023)